We are live on ! Find out more
PA

Pinnacle Associates Portfolio holdings

AUM $7.78B
1-Year Est. Return 45.07%
This Fund
S&P 500
This Quarter Est. Return
+13.68%
1 Year Est. Return
+45.07%
3 Year Est. Return
+102.47%
5 Year Est. Return
+115.95%
10 Year Est. Return
+586.2%
AUM
$7.54B
AUM Growth
+$629M
Cap. Flow
-$119M
Cap. Flow %
-1.58%
Top 10 Hldgs %
23.88%
Holding
885
New
40
Increased
248
Reduced
470
Closed
22

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$59.1M
2
FARO
Faro Technologies
FARO
+$13.3M
3
AAPL icon
Apple
AAPL
+$7.93M
4
MP icon
MP Materials
MP
+$7.83M
5
LITE icon
Lumentum
LITE
+$6.96M

Sector Composition

Rank Sector Weight
1 Technology 23.99%
2 Financials 11.05%
3 Healthcare 9.83%
4 Industrials 8.87%
5 Communication Services 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXP icon
26
American Express
AXP
$229B
$54.6M 0.73%
164,500
-649
-0.4% -$206K
BRK.B icon
27
Berkshire Hathaway Class B
BRK.B
$1.07T
$54.5M 0.72%
108,438
-1,166
-1% -$565K
CAT icon
28
Caterpillar
CAT
$402B
$53.9M 0.72%
112,996
+334
+0.3% +$143K
WMT icon
29
Walmart Inc
WMT
$889B
$50.3M 0.67%
488,068
-2,871
-0.6% -$286K
CSCO icon
30
Cisco
CSCO
$452B
$48.8M 0.65%
712,597
-5,513
-0.8% -$376K
LLY icon
31
Eli Lilly
LLY
$1.07T
$48.5M 0.64%
63,627
+9,445
+17% +$7.03M
BLK icon
32
Blackrock
BLK
$165B
$48M 0.64%
41,139
-4
-0% -$4.47K
REGN icon
33
Regeneron Pharmaceuticals
REGN
$69.9B
$47.3M 0.63%
84,191
+15,265
+22% +$8.63M
BAC icon
34
Bank of America
BAC
$436B
$46.4M 0.62%
899,808
-22,008
-2% -$1.07M
XYL icon
35
Xylem
XYL
$28.6B
$44.1M 0.59%
299,029
-15,352
-5% -$2.13M
ETN icon
36
Eaton
ETN
$155B
$44M 0.58%
117,561
+5,382
+5% +$1.96M
VGT icon
37
Vanguard Information Technology ETF
VGT
$138B
$43M 0.57%
460,768
-20,832
-4% -$1.82M
GLNG icon
38
Golar LNG
GLNG
$4.99B
$41.8M 0.55%
1,034,336
-39,630
-4% -$1.64M
COHR icon
39
Coherent
COHR
$53.1B
$41.5M 0.55%
385,488
-27,587
-7% -$2.75M
SCHD icon
40
Schwab US Dividend Equity ETF
SCHD
$103B
$40.3M 0.53%
1,475,986
-51,757
-3% -$1.41M
IBM icon
41
IBM
IBM
$204B
$39.7M 0.53%
140,788
+250
+0.2% +$65.4K
ABBV icon
42
AbbVie
ABBV
$454B
$39.7M 0.53%
171,419
+2,859
+2% +$582K
JEPI icon
43
JPMorgan Equity Premium Income ETF
JEPI
$45.6B
$39.7M 0.53%
694,836
+11,061
+2% +$628K
RTX icon
44
RTX Corp
RTX
$294B
$39M 0.52%
232,834
-1,716
-0.7% -$266K
MRK icon
45
Merck
MRK
$323B
$37.2M 0.49%
443,116
+292
+0.1% +$24.1K
MKL icon
46
Markel Group
MKL
$25.2B
$35.2M 0.47%
18,407
-295
-2% -$578K
BX icon
47
Blackstone
BX
$106B
$35M 0.46%
204,803
-2,639
-1% -$452K
MDY icon
48
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.9B
$34.8M 0.46%
58,366
-781
-1% -$458K
PG icon
49
Procter & Gamble
PG
$346B
$34.3M 0.46%
223,170
-902
-0.4% -$141K
C icon
50
Citigroup
C
$223B
$34.1M 0.45%
336,357
-3,788
-1% -$359K

Similar funds

Pinnacle Associates's Q3 2025 Portfolio in Review

As of Q3 2025, Pinnacle Associates held 885 positions worth $7.54B, up 9.1% from $6.91B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Pinnacle Associates's Q3 2025 filing shows 40 new, 248 increased, 470 reduced and 22 closed positions. Its largest new stake was Cedar Fair: 205,567 shares worth $4.67M. The largest sale was Johnson & Johnson, an estimated $59.1M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Pinnacle Associates's largest Q3 2025 buy was Cedar Fair: 205,567 shares worth $4.67M.
  • Pinnacle Associates added most to Regeneron Pharmaceuticals in Q3 2025, an estimated $8.63M increase.
  • Pinnacle Associates's biggest Q3 2025 reduction was Johnson & Johnson, cutting an estimated $59.1M.
  • Pinnacle Associates fully exited Faro Technologies in Q3 2025, selling an estimated $13.3M.
  • Pinnacle Associates's ten largest holdings make up 24% of its $7.54B portfolio in Q3 2025.
  • Pinnacle Associates opened 40 new positions and closed 22 in Q3 2025.
  • Pinnacle Associates's portfolio value rose 9.1% quarter-over-quarter to $7.54B.

Based on Pinnacle Associates's 13F filing for Q3 2025, filed 13 Nov 2025.